Back to results
US 2003/0069293 A1Published application
Medicament
AssigneeSmithKline Beecham Corporation
InventorJames Hill
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for primary and secondary prevention of infarction.
Claims11
A method of primary and secondary prevention of infarction in a mammal which comprises administering to a subject in need thereof an effective amount of an angiotensin II receptor antagonist.
Dependencies are inferred from the claim text.